Pharma Penny Stock Below Rs 20: Company Receives Order Worth Rs 12,59,50,000 from J D Healthcare

The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share.

JFL Life Sciences Ltd has secured a significant order from M/s J D Healthcare, as disclosed per Para B of Part A of Schedule III of the listing Regulations, 2015. This domestic order, detailed in a purchase order dated May 10, 2025, entails the supply of various Pharmaceutical, Lifecare, and Healthcare products. Valued at Rs 12,59,50,000.00, the order is to be executed within nine months from the date of the purchase order, marking a notable development for the company.

JFL Life Sciences Limited, a WHO-GMP-certified Indian pharmaceutical company established in 2010, manufactures a diverse range of products including dry powder injections, tablets, capsules, and oral rehydration solutions. With a focus on B-Lactam formulations, the company offers over 320 products across various dosage forms. The company has a market cap of Rs 59 crore and has delivered good profit growth of 61.6 per cent CAGR over the last 5 years. 

The promoters of the company hold 67.47 per cent and the public owns a 32.53 per cent stake in the company as of March 2025. The shares of the company have a PE of 10x whereas the industry PE is 35x. The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share.

Disclaimer: The article is for informational purposes only and not investment advice.